Budd-Chiari syndrome presenting as fulminant hepatic failure

Similar documents
Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association

hepatitis type A, B and non-a non-b

PORTAL HYPERTENSION. Tianjin Medical University LIU JIAN

Liver failure &portal hypertension

ABNORMAL LIVER FUNCTION TESTS. Dr Uthayanan Chelvaratnam Hepatology Consultant North Bristol NHS Trust

Ulcerative colitis complicated by Budd-Chiari syndrome

MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT

Ascites Management. Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology

SPECIFIC ANTIBODIES TO HALOTHANE-INDUCED LIVER ANTIGENS IN HALOTHANE-ASSOCIATED HEPATITIS

Hepatocytes produce. Proteins Clotting factors Hormones. Bile Flow

Prognosis of untreated Primary Sclerosing Cholangitis (PSC) Erik Christensen Copenhagen, Denmark

Patterns of abnormal LFTs and their differential diagnosis

Diseases of liver. Dr. Mohamed. A. Mahdi 4/2/2019. Mob:

Study of liver biochemical profiles in congestive heart failure patients in Government Dharmapuri Medical College, Dharmapuri

Drug Induced Liver Injury (DILI)

Suspected Isoflurane Induced Hepatitis from Cross Sensitivity in a Post Transplant for Fulminant Hepatitis from Halothane.

Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic

Jaundice. Agnieszka Dobrowolska- Zachwieja, MD, PhD

LIVER CIRRHOSIS. The liver extracts nutrients from the blood and processes them for later use.

Approach to the Patient with Liver Disease

Observational Medical Outcomes Partnership

King s College Hospital NHS Foundation Trust. Acute Liver Disease: what you really need to know.

Patterns of abnormal LFTs and their differential diagnosis

Clinical presentation and predictors of survival in patients with Budd Chiari Syndrome: Experience from a tertiary care hospital in Pakistan

MANAGEMENT OF ACUTE HEPATIC FAILURE

LIVER PHYSIOLOGY AND DISEASE

Primary sclerosing cholangitis in India

Hepatocellular Carcinoma: Diagnosis and Management

CHAPTER 1. Alcoholic Liver Disease

Good afternoon. Thanks, John, very much for the invitation to be here today. I am delighted to discuss elevated transaminases in the setting of heart

Laboratory Tests and Diagnostic Procedures in Liver Disease: Adventures in Liverland

PITFALLS IN THE DIAGNOSIS OF MEDICAL LIVER DISEASE WITH TWO CONCURRENT ETIOLOGIES I HAVE NOTHING TO DISCLOSE CURRENT ISSUES IN ANATOMIC PATHOLOGY 2017

Update in abdominal Surgery in cirrhotic patients

Podcast (Video Recorded Lecture Series): Portal HTN and Derivatives for the USMLE Step One Exam. Ultrasound (w/ doppler) Reversal of flow Portal Vein

WEEK. MPharm Programme. Liver Biochemistry. Slide 1 of 49 MPHM14 Liver Biochemistry

CrackCast Episode 28 Jaundice

Case Scenario 1. Discharge Summary

EDUCATION PRACTICE. Management of Refractory Ascites. Clinical Scenario. The Problem

International Journal of Pharma and Bio Sciences AN INTERESTING CASE OF SUBACUTE BUDD-CHIARI SYNDROME ABSTRACT

World Health Organization. Western Pacific Region

Department of Clinical Haematology Oxford BMT Programme Management of Hepatic Veno-occlusive Disease (VOD)

INCREASED resistance to blood flow in the liver or portal venous system results

Non-infectious hepatic complications in patients with GVHD

Module 1 Introduction of hepatitis

What Is Cirrhosis? CIRRHOSIS. Cirrhosis occurs when the liver is. by chronic conditions and diseases. permanently scarred or injured

cerebral oedema of fulminant hepatic failure

Staging & Current treatment of HCC

Anaesthetic considerations and peri-operative risks in patients with liver disease

Gastrointestinal System: Accessory Organ Disorders

ISOVALERIC ACIDAEMIA -ACUTE DECOMPENSATION (standard version)

The Heart in Concert: Do Other Organs Matter? The Liver

Early Klebsiella pneumoniae Liver Abscesses associated with Pylephlebitis Mimic

Significance of increased 'splenic uptake' on liver

Liver Failure. The most severe clinical consequence of liver disease is liver failure:

KEY FACTS IN ANAESTHESIA AND INTENSIVE CARE

SMALL ANIMAL SOFT TISSUE CASE-BASED EXAMINATION

Complications of Cirrhosis

Karen A. Hicks, M.D. Medical Officer Division of Cardiovascular and Renal Products Center for Drug Evaluation and Research, FDA

Radiology of hepatobiliary diseases

PREOPERATIVE ASSESSMENT OF THE PATIENT WITH LIVER DYSFUNCTION

Investigations before OLT, Immunosuppression and rejection, Follow up after OLT.

Investigating and Referring Incidental Findings of Abnormal Liver Tests

Viral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a

EVALUATION OF ABNORMAL LIVER TESTS

POSTGRADUATE INSTITUTE OF MEDICINE UNIVERSITY OF COLOMBO MP (PAEDIATRICS) EXAMINATION - JULY/AUGUST 2012' PAPER I STRUCTURED ESSAY QUESTIONS

Hepatology cases for the generalist. Will Gelson Consultant Hepatologist Addenbrooke s Hospital

Alpha-1 Antitrypsin Deficiency: Liver Disease

POSTGRADUATE INSTITUTE OF MEDICINE UNIVERSITY OF COLOMBO

Obliterative hepatocavopathy ultrasound and cavography findings

Hepatitis C Update on New Treatments

King Abdul-Aziz University Hospital (KAUH) is a tertiary

DISEASE LEVEL MEDICAL EVIDENCE PROTOCOL

Clinical Case Maria Butí, MD, PhD

Hepatology for the Nonhepatologist

Etiology of liver cirrhosis

CITY AND HACKNEY CCG ABNORMAL LIVER FUNCTION TESTS (LFTs) in ADULTS

Imaging of liver and pancreas

LIVER DISEASES. Pathology Department, Zhejiang University School of Medicine,

Investigating the patient with ascites

ATTENDING PHYSICIAN'S STATEMENT FULMINANT VIRAL HEPATITIS / HEPATITIS WITH CIRRHOSIS

Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals. By: Dr. Kevin Dolehide

A case of acute budd chiarri syndrome due to heparin induced thrombosis. DR.VINAY BHOMIA MD

BUDD-CHIARI SYNDROME DUE TO INFERIOR VENA CAVA OBSTRUCTION

London Strategic Clinical Networks. My AKI. Guidance for patients with, or recovering from, acute kidney injury

Lymphoma and Hematological Conditions: I. Lymphoma and Liver Complications of Bone Marrow Transplant

What is meant by Thrombotic Microangiopathy (TMA)?

The Leeds Teaching Hospitals NHS Trust Transjugular Intrahepatic Portosystemic Shunt (TIPS)

British Liver Transplant Group Pathology meeting September Leeds cases

Resident, PGY1 David Geffen School of Medicine at UCLA. Los Angeles Society of Pathology Resident and Fellow Symposium 2013

Appendix 5. EFSUMB Newsletter. Gastroenterological Ultrasound

Successful Treatment of Hepatic Venocclusive Disease in a Bone Marrow Transplant Patient With Side-to-Side Portacaval Shunt

Multiple Primary Quiz

Management of autoimmune hepatitis. Pierre-Emmanuel RAUTOU Inserm U970, Paris Service d hépatologie, Hôpital Beaujon, Clichy, France

Contraindications. Indications. Complications. Currently TIPS is considered second or third line therapy for:

The Egyptian Journal of Hospital Medicine (July 2018) Vol. 72 (10), Page

Disorders of the Liver, Gallbladder and Pancreas

European Society of Anaesthesiologists MANAGEMENT OF LIVER FAILURE

Hepatocellular Carcinoma (HCC)

Transcription:

Gut, 1986, 27, 1101-1105 Case reports Budd-Chiari syndrome presenting as fulminant hepatic failure P R POWELL-JACKSON, R J EDE, AND ROGER WILLIAMS From the Liver Unit, King's College School of Medicine and Dentistry, Denmark Hill, London SUMMARY Two cases of the Budd-Chiari syndrome are described in whom the diagnosis was finally confirmed at necropsy. The presentation was with encephalopathy, occurring within eight weeks of first symptoms and coming therefore within the definition of fulminant hepatic failure. In one, thought to have non-a, non-b hepatitis, encephalopathy progressed to grade 4 coma with death 12 days after presentation. In the other, mistakenly thought to have intra-abdominal malignancy, an exploratory laparotomy exacerbated the encephalopathy with death three weeks later. In neither case were non-invasive investigations, such as ultrasound and isotope scanning, carried out which might have facilitated an earlier diagnosis and consideration for orthotopic liver transplantation, probably the most appropriate form of therapy for these very severe cases. Most cases of the Budd-Chiari syndrome present with a subacute illness characterised by painful hepatomegaly and tense ascites. In occasional instances the diagnosis may be made during the investigation of an apparent cryptogenic cirrhosis but, in the present report, we describe two cases presenting at the other end of the spectrum. These patients developed hepatic encephalopathy within eight weeks of first symptoms of the illness and without evidence of previous liver disease, and come within the definition of fulminant hepatic failure.1 As this mode of presentation is not described in any of the published series,2-5 we have considered the diagnostic difficulties posed by these two cases and the possible treatment measures. Case reports CASE 1 A 27 year old man was admitted to hospital on 30 May, 1980 with an eight day history of lower abdominal pain, vomiting, and watery brown diarrhoea. Over the next two days he became progressively oliguric and drowsy with blood cultures sterile Address for correspondence: Dr Roger Williams FRCP, Liver Unit, King's College School of Medicine and Dentistry, Denmark Hill, London SE5 8RX. Received for publication 13 December 1985. on two occasions. On transfer to this Unit on 3 June, he was in grade IV encephalopathy, deeply jaundiced, hyperventilating and hyperreflexic. The liver was impalpable and the spleen enlarged 5 cm below the left costal margin. The abdomen was not distended and had minimal shifting dullness in the flanks. Investigations carried out after transfer to this Unit showed a normal haemoglobin concentration of 14 6 g/dl. a raised white cell count of 35.9x 109/l with a neutrophilia of 86% and left shift. The prothrombin time was 45 seconds (control 12 seconds). There was evidence of a metabolic acidosis and renal failure with the following plasma concentrations: sodium 127 mmol/l, potassium 5.7 mmol/l, bicarbonate 13 mmol/l, creatinine 1018 tmol/l, glucose 9.8 mmol/l. Arterial blood gases on air: P02 10-81 kpa, PCO2 3.41 kpa, ph 7X32, standard bicarbonate -11X5 mmol/l. Liver function tests: bilirubin 316 jimol/l, alkaline phosphatase 270 IU/l, aspartate aminotransferase 353 IU/l, total protein 55 g/l and albumin 30 g/l. Serum immunoglobulin, copper and caeruloplasmin concentrations were normal and serological tests for hepatitis A and B, Epstein Barr virus, cytomegalovirus, toxoplasma and leptospirosis were negative. The urine:plasma osmolality ratio was less than 1X1:1. Microscopic examination of an ascitic tap revealed scanty gram positive cocci and blood cultures grew Strep faecalis. 1101

1102 He was treated with intravenous antibiotics (ampicillin, cefuroxime, and metronidazole) and our standard anti-liver failure regimen.6 Haemodialysis was started but, after 24 hours, pupillary responses became unequal because of cerebral oedema and mechanical ventilation became necessary because of deteriorating blood gases. Death occurred on 10 June. LIVER PATHOLOGY A percutaneous liver biopsy obtained immediately after death showed features of acute outflow venous block with confluent areas of haemorrhagic necrosis which in places involved all zones of the liver acinus (Fig. 1). At necropsy there were three litres of slightly blood stained ascitic fluid and the liver was enlarged (weight 2600 g), its cut surface showing patchy congestion particularly around branches of the hepatic veins. The latter contained thrombi undergoing various degrees of organisation with some completely fibrosed. The orifices of the hepatic veins were small and scarred and contained recent thrombus. The spleen was enlarged (weight 830 g), firm and congested, with numerous haemorrhagic infarcts. Powell-Jackson, Ede, and Williams CASE 2 A 43 year old woman was admitted to her local hospital on 30 June, 1978 with a two day history of abdominal pain and distension preceded for five days by diarrhoea and vomiting. On examination she was drowsy, confused, and disorientated. The abdomen was distended and tender in the right upper quadrant and there was shifting dullness but no masses were felt. Investigations showed a raised haemoglobin concentration of 17-6 g/dl, a raised white cell count of 34-9x 109/l with a neutrophilia of 83% and left shift. Liver function tests showed evidence of acute hepatocellular injury: bilirubin 48 [smolul, alkaline phosphatase 130 IU/l, aspartate aminotransferase 936 IU/l, total protein 60 g/l and albumin 34 g/l. A diagnosis of intra-abdominal malignancy was made and laparotomy was undertaken three days later. At operation, the liver and spleen were both tense, smooth and enlarged and there was no evidence of malignancy. The ascites was gross and during the subsequent eight days it rapidly reaccumulated and leaked through the wound. There was a concomitant fall in serum sodium concentration to 94 mmol/l and rise in potassium to *'X4+bs..J >_ ;%6-w V- :e.:. Fig. 1 Liver obtained by percutaneous biopsy in patient 1. There are features ofacute outflow venous block with confluent areas ofhaemorrhagic necrosis (arrowed). HV: hepatic venule. PT: portal tract. H and E.

Budd-Chiari syndrome presenting as fulminant hepatic failure ~~Xe~ ji:. ft *V5 *M,-.+ V 1103 gsa~~~~~~~~~~~~~~~~ Fig. 2a Liver taken at surgery in patient 2. There is extensive hepatocyte loss and congestion throughout zones 2 and 3 (arrowed). Note afresh thrombus obliterating an hepaiic vein branch (HV). PT: portal traci. H and E. Fig. 2b Liver at post mortem from the same patient as Fig. 2a. There are only occasional islands of surviving hepatocytes (arrowed) around portal tracts (PT). HV:hepatic vein. H and E.

1104 Powell-Jackson, Ede, and Williams 7-2 mmol/l. At the time of transfer to King's College Hospital the patient had developed worsening encephalopathy and evidence of functional renal failure. Liver function tests had deteriorated: bilirubin 580 Rmol/l, alkaline phosphatase 330 IU/l, aspartate aminotransferase 371 IU/l, total protein 52 g/l, albumin 25 g/l, prothrombin time 35 seconds (control 13 seconds). She was treated with intravenous antibiotics, salt poor albumin, sodium and protein restriction, and an infusion of streptokinase and plasminogen. The latter was stopped after 24 hours because of widespread bleeding which continued for a further 12 hours. Despite these measures she became progressively more jaundiced over the 12 days (bilirubin concentration rising to 1050 [tmol/l) and died after an upper gastrointestinal bleed. LIVER PATHOLOGY A wedge biopsy obtained at laparotomy showed the features of outflow venous block with extensive liver cell loss throughout zones 2 and 3, and fresh thrombus in some venules (Fig. 2a). At necropsy the liver was shrunken (1250 g) except for the caudate lobe which was enlarged, tense, and congested. The left hepatic vein contained organised mural thrombus although the lumen was patent. The right hepatic vein was patent. Microscopic examination of the liver showed areas of haemorrhagic necrosis involving all zones of the lobule (Fig. 2b). The spleen was congested (weight 290 g) and contained one haemorrhagic infarct. Sections of bone marrow showed complete replacement by hypercellular haemopoietic tissue consistent with polycythaemia rubra vera. Discussion The diagnosis made during life in the first case was that of fulminant hepatic failure from non-a, non-b infection, the classical features of the Budd-Chiari syndrome of tender hepatomegaly and tense ascites being conspicuously absent. In retrospect, greater attention should have been paid to the finding of splenomegaly as the degree of enlargement present is unusual in fulminant viral hepatitis, although it is to be found in about a third of patients with the Budd-Chiari syndrome.3 In the second case, the confidence with which signs of tender hepatomegaly and ascites were attributed to intra-abdominal malignancy was such that the surgeon did not request any non-invasive investigations of the liver. Abdominal ultrasound examination and/or 99mTc sulphur colloid scintigraphy of the liver are likely to have given a positive lead to the diagnosis of the Budd-Chiari syndrome and thereby prevented the unnecessary laparotomy which was so deleterious. Since 1972, eight other patients with this disease have been referred to this Unit because of rapid deterioration after laparotomy and all developed renal impairment or severe electrolyte abnormalities. Two of them became mildly encephalopathic after surgery although, in contrast with the cases reported here, there was no evidence of encephalopathy before surgery. The detrimental consequences of laparotomy are related to the effect of general anaesthesia on hepatic blood flow7 and to the fluid and electrolyte changes resulting from the loss of ascitic fluid at operation and subsequently because of leakage through the abdominal wound. Hepatic decompensation with the development of encephalopathy after laparotomy has been described previously in the Budd-Chiari syndrome 5 8- as well as in acute hepatitis and cirrhosis.10 In the two cases reported here in which the presentation came within the definition of fulminant hepatic failure, there was biochemical and histological evidence of very extensive haemorrhagic infarction of the liver. This is consistent with the observation that in the more acute cases, the abnormalities in serum transaminase concentrations and prothrombin time are greatest.4 The evidence at necropsy for earlier and clinically silent episodes of hepatic vein thrombosis have also been reported in the more typical subacute and chronic cases.2 The only possible treatment in our view for such cases is hepatic transplantation. Decompression of the portal system by shunting would be expected to carry a very high mortality in the presence of such extensive hepatic necrosis, and the encouraging experience to date with orthotopic liver transplantation in fulminant and subacute hepatic failure from other causes would point to this as being the more appropriate line of therapy." The authors are indebted to Dr Bernard Portmann, Consultant Histopathologist, for the histological assessments. References 1 Trey C, Davidson CC. The management of fulminant hepatic failure. In: Popper H, Schaffner F, eds. Progress in liver diseases. Vol. III, New York: Grune and Stratton, 1970: 292-8. 2 Parker RGF. Occlusion of the hepatic veins in man. Medicine (Balt) 159; 38: 369-402. 3 Tavill AS, Wood EJ, Kreel L, et al. The Budd-Chiari syndrome: correlation between hepatic scintigraphy and the clinical, radiological and pathological findings in nineteen cases of hepatic venous outflow obstruction. Gastroenterology 1975; 68: 509-18.

Budd-Chiari syndrome presenting as fulminant hepatic failure 1105 4 Powell-Jackson PR, Melia W, Canalese J, et al. Budd- Chiari syndrome: clinical patterns and therapy. Q J Med 1982; 51: 79-88. 5 Langer B, Stone R, Colapinto R, et al. Clinical spectrum of the Budd-Chiari syndrome and its surgical management. Am J Surg 2975; 129: 137-45. 6 Williams R. The management of liver failure. In: Weatherall DJ, ed. Advanced medicine. Vol. 14. London: Pitman Medical, 1978: 19-29. 7 Strunin L. Anaesthetic management of patients with liver disease. In: Wright R, Alberti KGMM, Karran S et al, eds. Liver and biliary disease London: Saunders, 1979. 8 Bethelot P, Mignon F, Maillard JN. Syndrome aigu de Budd-Chiari. Aspects cliniques et biologiques de deux observations. Rev Med Chir Mal Foie 1969;44: 25-8. 9 Sandle G, Layton M, Record C, et al. Fulminant hepatic failure due to Budd-Chiari syndrome. Lancet 1980; i: 1199. 10 Powell-Jackson PR, Greenway B, Williams R. Adverse effects of exploratory laparotomy in patients with unsuspected liver disease. Br J Surg 1982; 69: 449-51. 11 Williams R, Gimson AES. An assessment of orthotopic liver tranplantation in acute liver failure. Hepatology 1984; 4: 22S-4S.